North American Morning Briefing: Stock Futures -2-
MGT Capital Investments (MGTI) is expected to report for 4Q.
NantHealth Inc (NHIQ) is expected to report $-0.20 for 4Q.
Oncotelic Therapeutics Inc (OTLC) is expected to report for 4Q.
Regional Health Properties Inc (RHE) is expected to report for 4Q.
Reliv International Inc (RELV) is expected to report for 4Q.
Richelieu Hardware (RCH.T) is expected to report $0.26 for 1Q.
Scorpius Holdings Inc (SCPX) is expected to report for 4Q.
Sientra Inc (SIENQ) is expected to report for 4Q.
StageZero Life Sciences Ltd (SZLS.T) is expected to report for 4Q.
Technical Communications Corp (TCCO) is expected to report for 1Q.
ViewRay Inc (VRAYQ) is expected to report $-0.22 for 1Q.
WM Technology Inc (MAPS) is expected to report $-0.01 for 4Q.
Windtree Therapeutics Inc (WINT) is expected to report $-0.94 for 4Q.
Powered by Kantar Media and Dow Jones.
ANALYST RATINGS ACTIONS
Albemarle Raised to Buy From Neutral by B of A Securities
Arch Resources Cut to Market Perform From Outperform by BMO Capital
Arthur J Gallagher & Co Cut to Hold From Buy by Truist Securities
Cava Group Raised to Buy From Hold by Argus Research
Century Casinos Raised to Outperform From Neutral by Macquarie
Certara Raised to Overweight From Sector Weight by Keybanc
CF Industries Cut to Neutral From Buy by B of A Securities
Deckers Outdoor Cut to Hold From Buy by Truist Securities
EQT Corp Raised to Market Perform From Underperform by Bernstein
FirstCash Holdings Raised to Buy From Hold by TD Cowen
GoodRx Holdings Raised to Overweight From Sector Weight by Keybanc
Health Catalyst Cut to Sector Weight From Overweight by Keybanc
Hexcel Cut to Neutral From Buy by Northcoast Research
Hexcel Cut to Underperform From Neutral by B of A Securities
Intellicheck Cut to Market Perform From Outperform by Northland Capital Markets
Intl Flavors & Fragrances Raised to Buy From Neutral by Citigroup
Ionis Pharmaceuticals Raised to Outperform From Peer Perform by Wolfe Research
KAR Auction Raised to Neutral From Underperform by B of A Securities
Luminar Technologies Cut to Underperform From Neutral by B of A Securities
Model N Cut to Equal-Weight From Overweight by Morgan Stanley
R1 RCM Cut to Sector Weight From Overweight by Keybanc
Revolution Medicines Raised to Strong Buy From Outperform by Raymond James
UDR Inc Raised to Neutral From Underweight by Piper Sandler
Visteon Raised to Overweight From Equal-Weight by Barclays
Yum Brands Cut to Hold From Buy by Argus Research
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
April 11, 2024 06:22 ET (10:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks